Garrison Bradford & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Sell
7,200
-250
-3% -$120K 3.92% 10
2026
Q1
$3.66M Sell
7,450
-2,150
-22% -$1.17M 4.14% 9
2025
Q4
$5.56M Sell
9,600
-525
-5% -$297K 6.04% 6
2025
Q3
$4.91M Sell
10,125
-230
-2% -$107K 5.25% 6
2025
Q2
$4.2M Hold
10,355
4.65% 8
2025
Q1
$5.15M Hold
10,355
5.67% 7
2024
Q4
$5.39M Hold
10,355
5.64% 7
2024
Q3
$6.41M Sell
10,355
-545
-5% -$323K 6.35% 6
2024
Q2
$6.03M Sell
10,900
-780
-7% -$447K 6.19% 6
2024
Q1
$6.79M Sell
11,680
-107
-0.9% -$60K 7% 6
2023
Q4
$6.26M Sell
11,787
-80
-0.7% -$38.7K 6.9% 5
2023
Q3
$6.01M Hold
11,867
7.09% 5
2023
Q2
$6.19M Hold
11,867
7.48% 4
2023
Q1
$6.84M Hold
11,867
8.47% 2
2022
Q4
$6.54M Sell
11,867
-345
-3% -$183K 7.93% 2
2022
Q3
$6.19M Sell
12,212
-200
-2% -$112K 7.54% 3
2022
Q2
$6.74M Hold
12,412
7.67% 2
2022
Q1
$7.33M Sell
12,412
-300
-2% -$172K 7.12% 4
2021
Q4
$8.48M Sell
12,712
-60
-0.5% -$37.5K 7.61% 3
2021
Q3
$7.3M Hold
12,772
7.42% 3
2021
Q2
$6.44M Hold
12,772
6.7% 3
2021
Q1
$5.83M Hold
12,772
6.5% 4
2020
Q4
$5.95M Sell
12,772
-628
-5% -$294K 7.25% 2
2020
Q3
$5.92M Hold
13,400
8.34% 2
2020
Q2
$4.86M Hold
13,400
7.05% 2
2020
Q1
$3.8M Sell
13,400
-300
-2% -$94.6K 6.5% 5
2019
Q4
$4.45M Sell
13,700
-100
-0.7% -$30.3K 5.58% 5
2019
Q3
$4.02M Sell
13,800
-1,500
-10% -$430K 5.48% 5
2019
Q2
$4.49M Sell
15,300
-3,650
-19% -$1.01M 5.26% 4
2019
Q1
$5.19M Hold
18,950
4.4% 5
2018
Q4
$4.24M Hold
18,950
3.83% 4
2018
Q3
$4.63M Sell
18,950
-2,000
-10% -$460K 3.73% 6
2018
Q2
$4.34M Hold
20,950
3.56% 6
2018
Q1
$4.33M Hold
20,950
3.68% 6
2017
Q4
$3.98M Sell
20,950
-2,703
-11% -$518K 3.29% 9
2017
Q3
$4.47M Buy
23,653
+1
+0% +$181 3.75% 6
2017
Q2
$4.13M Hold
23,652
3.57% 6
2017
Q1
$3.63M Hold
23,652
3.21% 9
2016
Q4
$3.34M Buy
23,652
+1
+0% +$147 3.08% 9
2016
Q3
$3.76M Hold
23,651
3.54% 6
2016
Q2
$3.5M Buy
23,651
+1
+0% +$148 3.43% 7
2016
Q1
$3.35M Hold
23,650
3.9% 6
2015
Q4
$3.35M Sell
23,650
-350
-1% -$46.7K 3.76% 6
2015
Q3
$2.94M Buy
24,000
+850
+4% +$111K 3.24% 7
2015
Q2
$3M Hold
23,150
2.93% 9
2015
Q1
$3.11M Hold
23,150
2.9% 7
2014
Q4
$2.9M Buy
23,150
+1,000
+5% +$122K 2.63% 10
2014
Q3
$2.7M Sell
22,150
-300
-1% -$36.5K 2.7% 11
2014
Q2
$2.65M Sell
22,450
-2,700
-11% -$318K 2.47% 11
2014
Q1
$3.02M Hold
25,150
2.91% 8
2013
Q4
$2.8M Hold
25,150
2.65% 11
2013
Q3
$2.32M Hold
25,150
2.37% 13
2013
Q2
$2.13M Buy
+25,150
New +$2.09M 2.29% 13

Other funds holding TMO

Garrison Bradford & Associates's TMO Position: Q2 2026 in Review

Garrison Bradford & Associates reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q2 2026, selling an estimated $120K and leaving 7,200 shares worth $3.61M. The position accounts for 3.92% of the portfolio, ranked #10.

Garrison Bradford & Associates first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.48M in Q4 2021. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Garrison Bradford & Associates held 7,200 shares of Thermo Fisher Scientific worth $3.61M as of Q2 2026.
  • Garrison Bradford & Associates sold 250 Thermo Fisher Scientific shares in Q2 2026, an estimated $120K.
  • Thermo Fisher Scientific made up 3.92% of Garrison Bradford & Associates's portfolio in Q2 2026, its #10 holding.
  • Garrison Bradford & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Garrison Bradford & Associates's Thermo Fisher Scientific position peaked at $8.48M in Q4 2021.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Garrison Bradford & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.